1000 |
Colon cancer test tissue array (4x (2x3) array),including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1008 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases_102 cores |
|
362.09 € |
- |
Biomax |
1010 |
Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1011 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1031 |
Rectum adenocarcinoma tissue array, including TNM and pathology grade, 48 cases_96 cores |
|
315.86 € |
- |
Biomax |
1050 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC07014 |
|
227.27 € |
- |
Biomax |
1054 |
Adjacent normal kidney tissue and cancer tissue array, including TNM, clinical stage and pathology grade, 20 cases_54 cores, replacing BN07011 |
|
256.80 € |
- |
Biomax |
1057 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1058 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1081 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases_24 cores |
|
110.42 € |
- |
Biomax |
1098 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
315.86 € |
- |
Biomax |
1099 |
Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
315.86 € |
- |
Biomax |
1102 |
Kidney cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T072 |
|
128.40 € |
- |
Biomax |
1104 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1106 |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BRN801 |
|
327.42 € |
- |
Biomax |
1108 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases_10 cores |
|
139.96 € |
- |
Biomax |
1112 |
Breast ductal intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases_48 cores |
|
274.78 € |
- |
Biomax |
1113 |
Breast cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC08013 |
|
256.80 € |
- |
Biomax |
1114 |
Breast cancer tissue array with adjacent normal breast tissue as control, including TNM, clinical stage and pathology grade, 110 cases_110 cores, replacing BC081116 |
|
362.09 € |
- |
Biomax |
1120 |
Breast cancer tissue array, including TNM and pathology grade, 4 cases_8 cores |
|
139.96 € |
- |
Biomax |
1121 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replacing BR10010 |
|
362.09 € |
- |
Biomax |
1122 |
Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases_ 100 cores, replacing BR1002 |
|
403.18 € |
- |
Biomax |
1124 |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replacing BR1005 |
|
362.09 € |
- |
Biomax |
1129 |
Breast cancer tissue array with lymph node positive and negative, including TNM, clinical stage and pathology grade, 98cases_ 110cores |
|
467.38 € |
- |
Biomax |
1130 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, p53, AR and Ki67, 75 cases_150 cores, replacing BR1503a |
|
362.09 € |
- |
Biomax |
1132 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores, replacing BR1505 |
|
362.09 € |
- |
Biomax |
1133 |
Breast cancer tissue array with cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 190 cases_ 192 cores, replacing BR1921 |
|
595.78 € |
- |
Biomax |
1135 |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 20 cases_ 20 cores |
|
274.78 € |
- |
Biomax |
1185 |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243i |
|
110.42 € |
- |
Biomax |
1188 |
Breast cancer tissue array, including TNM and pathology grade, 24cases_24 cores |
|
169.49 € |
- |
Biomax |
1189 |
Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases_ 24 cores |
|
169.49 € |
- |
Biomax |
1190 |
Breast mastitis tissue array, 20 cases_40 cores |
|
279.91 € |
- |
Biomax |
1191 |
Breast mastitis tissue array, 20 cases_ 40 cores |
|
279.91 € |
- |
Biomax |
1196 |
Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases_ 48 cores, replacing BR483 |
|
279.91 € |
- |
Biomax |
1197 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_ 48 cores, replacing BR484a |
|
362.09 € |
- |
Biomax |
1200 |
Breast fibroadenoma tissue array, 30 cases_ 60 cores, replacing BR601 |
|
327.42 € |
- |
Biomax |
1202 |
Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases_ 64 cores |
|
327.42 € |
- |
Biomax |
1220 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BR803 |
|
315.86 € |
- |
Biomax |
1221 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR804 |
|
327.42 € |
- |
Biomax |
1235 |
Breast disease spectrum tissue array, including TNM, clinical stage, pathology grade and IHC markers (PR, ER, Her-2), 48 cases_96 cores, replacing BR963 |
|
362.09 € |
- |
Biomax |
1236 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
279.91 € |
- |
Biomax |
1237 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 49 cases_96 cores |
|
309.44 € |
- |
Biomax |
1240 |
Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases_ 96 cores, |
|
356.95 € |
- |
Biomax |
1241 |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER_Ki67_PR_Her-2, 10 cases_10 cores |
|
139.96 € |
- |
Biomax |
1242 |
PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases_11 cores |
|
139.96 € |
- |
Biomax |
1243 |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T086b |
|
128.40 € |
- |
Biomax |
1244 |
Breast cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T087a |
|
128.40 € |
- |
Biomax |
1245 |
Breast cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing T088 |
|
128.40 € |
- |
Biomax |
1246 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1249 |
Endometrial carcinoma tissue array, clinical stage and pathology grade, 63 cases_ 63 cores, replacing BC09012 |
|
327.42 € |
- |
Biomax |
1254 |
Endometrium cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12cases_ 24cores, replacing T092 |
|
139.96 € |
- |
Biomax |
1255 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1261 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1262 |
Endometrioid adenocarcinoma and hyperplasia tissue array with adjacent tissue as control, including TNM, clinical stage and pathology grade, 24 cases_24 cores |
|
139.96 € |
- |
Biomax |
1266 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing UT243 |
|
128.40 € |
- |
Biomax |
1267 |
Choriocarcinoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores |
|
174.62 € |
- |
Biomax |
1273 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
279.91 € |
- |
Biomax |
1274 |
Endometrium tissue array, including TNM, clinical stage and pathology grade, 79 cases_80 cores |
|
467.38 € |
- |
Biomax |
1277 |
Cervical intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases_48 cores |
|
279.91 € |
- |
Biomax |
1282 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1298 |
Cervix cancer tissue array with matched adjacent cervix tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores,replacing CR245 |
|
139.96 € |
- |
Biomax |
1317 |
Cervix cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T102 |
|
139.96 € |
- |
Biomax |
1319 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1325 |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC11012 |
|
227.27 € |
- |
Biomax |
1331 |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases_100 cores, replacing OV1005 |
|
327.42 € |
- |
Biomax |
1356 |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing OV241 |
|
128.40 € |
- |
Biomax |
1368 |
Ovarian serous cystadenoma tissue array with normal tissue as control, 30 cases_60 cores, replacing OV603 |
|
327.42 € |
- |
Biomax |
1370 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases_70 cores, replacing BC111110 |
|
279.91 € |
- |
Biomax |
1371 |
Ovary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases_70 cores |
|
315.86 € |
- |
Biomax |
1375 |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing OV803 |
|
315.86 € |
- |
Biomax |
1383 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
279.91 € |
- |
Biomax |
1384 |
Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
279.91 € |
- |
Biomax |
1386 |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T112 |
|
110.42 € |
- |
Biomax |
1388 |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T113 |
|
110.42 € |
- |
Biomax |
1389 |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1391 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases_63 cores, replacing BC12011 |
|
245.24 € |
- |
Biomax |
1394 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores |
|
315.86 € |
- |
Biomax |
1402 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores |
|
128.40 € |
- |
Biomax |
1411 |
Normal bladder tissue array, including TNM, clinical stage and pathology grade, 40 cases_ 80 cores |
|
279.91 € |
- |
Biomax |
1412 |
Bladder cancer test tissue array, with normal bladder control tissues, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing T121 |
|
128.40 € |
- |
Biomax |
1414 |
Bladder cancer tissue array with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T124 |
|
139.96 € |
- |
Biomax |
1415 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1418 |
Pancreatitis tissue array, 48 cases_48 cores |
|
279.91 € |
- |
Biomax |
1419 |
Pancreas intraepithelial neoplasia, pancreatitis and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases_48 cores |
|
279.91 € |
- |
Biomax |
1426 |
Pancreas disease spectrum (pancreatic cancer progression) tissue array, including TNM, clinical stage and pathology grade, 103 cases_208 cores, replacing PA2081 |
|
595.78 € |
- |
Biomax |
1428 |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases_24 cores, replacing PA241 |
|
128.40 € |
- |
Biomax |
1429 |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing PA242 |
|
128.40 € |
- |
Biomax |
1433 |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases_48 cores, replacing PA483 |
|
227.27 € |
- |
Biomax |
1434 |
Pancreas cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases_48 cores, replacing PA483 |
|
227.27 € |
- |
Biomax |
1436 |
Pancreatitis and matched pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 43 cases_48 cores |
|
279.91 € |
- |
Biomax |
1440 |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing PA805 |
|
362.09 € |
- |
Biomax |
1442 |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases_96 cores, replacing PA961 |
|
362.09 € |
- |
Biomax |
1443 |
Pancreas tissue array with pancreas cancer tissue as control, including TNM and pathology grade, 24 cases_24 cores |
|
110.42 € |
- |
Biomax |
1444 |
Pancreas tissue array with pancreas cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores |
|
315.86 € |
- |
Biomax |
1445 |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases_24 cores, replacing T141 |
|
110.42 € |
- |
Biomax |
1446 |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing T142 |
|
128.40 € |
- |
Biomax |
1448 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1453 |
Thyroid cancer tissue array, including TNM and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1455 |
Thyroid disease spectrum tissue array, including TNM, clinical stage, 20 cases_ 20 cores |
|
256.80 € |
- |
Biomax |
1458 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases_24 cores |
|
110.42 € |
- |
Biomax |
1460 |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 32 cases_64 cores |
|
327.42 € |
- |
Biomax |
1463 |
Thyroid cancer tissue array with matched or unmatched adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 74 cases_80 cores, replacing TH801 |
|
362.09 € |
- |
Biomax |
1464 |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases_80 cores, replacing TH802 |
|
327.42 € |
- |
Biomax |
1473 |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases_80 cores, replacing TH809 |
|
362.09 € |
- |
Biomax |
1474 |
Thyroid disease tissue array, including TNM, clinical stage, 48 cases_ 96 cores |
|
362.09 € |
- |
Biomax |
1491 |
Normal brain tissue array, 26 cases_ 80 cores |
|
362.09 € |
- |
Biomax |
1492 |
Brain glioblastoma tissue array, including pathology grade, 40 cases_80 cores, replacing BS17016 |
|
327.42 € |
- |
Biomax |
1501 |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing GL2083 |
|
595.78 € |
- |
Biomax |
1502 |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases_24 cores, replacing GL241 |
|
110.42 € |
- |
Biomax |
1509 |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases_80 cores, replacing GL803 |
|
362.09 € |
- |
Biomax |
1515 |
Brain glioblastoma tissue array with normal brain tissue as control, including pathology grade, 40 cases_80 cores, replacing GL806a |
|
362.09 € |
- |
Biomax |
1519 |
Nervous system tumor tissue array, including clinical stage and pathology grade, 48 cases_96 cores |
|
362.09 € |
- |
Biomax |
1520 |
Meningioma of central nerve tissue array, 80 cases_80 cores, replacing MG801 |
|
362.09 € |
- |
Biomax |
1521 |
Brain tumor tissue array, 40 cases_80 cores |
|
362.09 € |
- |
Biomax |
1522 |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T173 |
|
128.40 € |
- |
Biomax |
1524 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases_24 cores, replacing T171 |
|
128.40 € |
- |
Biomax |
1525 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases_24 cores, replacing T172 |
|
128.40 € |
- |
Biomax |
1526 |
Brain tumor tissue array, including pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1532 |
Prostate intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases_48 cores |
|
256.80 € |
- |
Biomax |
1533 |
Prostate cancer and hyperplasia tissue array, including TNM, clinical stage and pathology grade, 32 cases_ 63 cores, replacing BC19017 |
|
327.42 € |
- |
Biomax |
1536 |
Normal prostate tissue array, 24 cases_ 48 cores, |
|
362.09 € |
- |
Biomax |
1539 |
High-density prostate cancer tissue array, including TNM, pathology grade, Gleason grade and Gleason scores, 114 cases_208 cores, replacing PR2085a |
|
595.78 € |
- |
Biomax |
1540 |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing PR242 |
|
128.40 € |
- |
Biomax |
1541 |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing PR243 |
|
128.40 € |
- |
Biomax |
1544 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_48 cores, replacing PR483 |
|
256.80 € |
- |
Biomax |
1545 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases_48 cores |
|
199.02 € |
- |
Biomax |
1548 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases_63 cores, replacing PR8010 |
|
362.09 € |
- |
Biomax |
1554 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing PR803 |
|
362.09 € |
- |
Biomax |
1562 |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases_80 cores, replacing PR807 |
|
362.09 € |
- |
Biomax |
1565 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases_95 cores, replacing PR956 |
|
595.78 € |
- |
Biomax |
1568 |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T195 |
|
128.40 € |
- |
Biomax |
1569 |
Prostate cancer test tissue array (4x (2x3) array),including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
128.40 € |
- |
Biomax |
1574 |
Normal lymph node tissue array, 30 cases_ 60 cores, |
|
403.18 € |
- |
Biomax |
1576 |
Hodgkin's lymphoma tissue array, 45 cases_80 cores, replacing HL801 |
|
362.09 € |
- |
Biomax |
1577 |
Multiple lymphoma tissue array with normal tissue as control, 48cases_ 48cores, replacing LM481 |
|
256.80 € |
- |
Biomax |
1578 |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases_48 cores, replacing LM482a |
|
391.62 € |
- |
Biomax |
1580 |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases_80 cores, replacing LM801 |
|
327.42 € |
- |
Biomax |
1582 |
Diffuse large-B cell lymphoma tissue array, 100 cases_100 cores, replacing LY1001 |
|
362.09 € |
- |
Biomax |
1583 |
Diffuse large B-cell lymphoma tissue array, 12 cases_12 cores, replacing LY121 |
|
227.27 € |
- |
Biomax |
1585 |
Lymphoma tissue array, 20 cases_ 20 cores |
|
227.27 € |
- |
Biomax |
1594 |
Lymphoma tumor tissue array, 208 cases_208 cores |
|
525.16 € |
- |
Biomax |
1598 |
Lymphoma, myeloma and lymph node tissue array, 40 cases_40 cores, replacing NHL401 |
|
362.09 € |
- |
Biomax |
1599 |
Lymphoma cancer tissue array, 48 cases_48 cores, replacing NHL482 |
|
279.91 € |
- |
Biomax |
1601 |
Non-Hodgkin's lymphoma tissue array, 42 cases_80 cores, replacing NHL802 |
|
327.42 € |
- |
Biomax |
1603 |
Lymphoma tissue array, 80 cases_80 cores, replacing NHL803b |
|
403.18 € |
- |
Biomax |
1604 |
Lymphoma tissue array, 80 cases_80 cores, replacing NHL803b |
|
403.18 € |
- |
Biomax |
1606 |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases_24 cores, replacing T203 |
|
128.40 € |
- |
Biomax |
1607 |
Lymphoma tissue tissue array with normal tissue as control, 2 serial sections, 6 cases_24 cores, replacing T204 |
|
128.40 € |
- |
Biomax |
1608 |
Lymphoma tissue array, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1611 |
Malignant melanoma with and benign nevus tissue array, clinical stage and pathology grade, 18 cases_18 cores |
|
233.69 € |
- |
Biomax |
1614 |
Skin cancer tissue array with adjacent normal skin tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing SK241 |
|
139.96 € |
- |
Biomax |
1616 |
Age grouped female skin tissue array, 12 cases_24 cores, replacing SK244 |
|
327.42 € |
- |
Biomax |
1617 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases_24 cores |
|
128.40 € |
- |
Biomax |
1623 |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing SK801 |
|
315.86 € |
- |
Biomax |
1624 |
Skin squamous cell cancer tissue array with normal skin tissue, including TNM, clinical stage and pathology grade,, 80 cases_80 cores, replacing SK802 |
|
362.09 € |
- |
Biomax |
1628 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores |
|
315.86 € |
- |
Biomax |
1630 |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T212 |
|
128.40 € |
- |
Biomax |
1632 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1644 |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases_24 cores, replacing T231 |
|
110.42 € |
- |
Biomax |
1651 |
Normal testis tissue array, 30 cases_ 60 cores |
|
279.91 € |
- |
Biomax |
1655 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases_96 cores |
|
279.91 € |
- |
Biomax |
1664 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases_75 cores, replacing BC24021 |
|
327.42 € |
- |
Biomax |
1679 |
Synovial sarcoma tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores |
|
403.18 € |
- |
Biomax |
1683 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1688 |
Osteochondroma tissue array with cancer adjacent normal tissue as control, 24 cases_ 24 cores |
|
174.62 € |
- |
Biomax |
1693 |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases_24 cores |
|
128.40 € |
- |
Biomax |
1694 |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases_24 cores, replacing BO244 |
|
110.42 € |
- |
Biomax |
1703 |
Bone and cartilage malignant tumor tissue array, including TNM and clinical stage, 6 cases_24 cores |
|
139.96 € |
- |
Biomax |
1709 |
Tonsil disease spectrum tissue array, 50 cases_100 cores |
|
362.09 € |
- |
Biomax |
1711 |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases_60 cores, replacing OR601 |
|
315.86 € |
- |
Biomax |
1722 |
Normal spleen tissue array, 24 cases_ 48 cores |
|
227.27 € |
- |
Biomax |
1730 |
Bone tumor, PNET, lymphoma and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482 |
|
525.16 € |
- |
Biomax |
1731 |
Myeloma tissue array with normal tissue as control, 6 cases_24 cores, replacing T291 |
|
139.96 € |
- |
Biomax |
1732 |
Bone marrow tumor and normal tissue array, including TNM, 6 cases_24 cores, replacing T293 |
|
139.96 € |
- |
Biomax |
1735 |
Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases_48 cores |
|
309.44 € |
- |
Biomax |
1741 |
Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases_24 cores |
|
263.22 € |
- |
Biomax |
1744 |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing HN241 |
|
110.42 € |
- |
Biomax |
1745 |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing HN242 |
|
110.42 € |
- |
Biomax |
1747 |
Head and neck squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing HN801 |
|
327.42 € |
- |
Biomax |
1749 |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing HN803 |
|
362.09 € |
- |
Biomax |
1751 |
Head and neck tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 27 cases_81 cores, replacing HN811 |
|
315.86 € |
- |
Biomax |
1753 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores |
|
110.42 € |
- |
Biomax |
1759 |
Mucosa malignant melanoma tissue array, 40 cases_80 cores |
|
327.42 € |
- |
Biomax |
1760 |
Metastatic malignant melanoma tissue array, 50 cases_100 cores |
|
327.42 € |
- |
Biomax |
1761 |
Malignant melanoma tissue array with normal tissue as control, 50cases_ 100cores, replacing ME1002 |
|
403.18 € |
- |
Biomax |
1762 |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases_100 cores, replacing ME1004 |
|
362.09 € |
- |
Biomax |
1766 |
Malignant melanoma tissue array with normal skin tissue, including TNM and clinical stage, 208 cases_208 cores, replacing ME2082a |
|
595.78 € |
- |
Biomax |
1767 |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases_24 cores, replacing ME241 |
|
128.40 € |
- |
Biomax |
1768 |
Malignant melanoma array with cancer adjacent normal tissue as contral, including TNM, clinical stage and pathology grade, 24 cases_24 cores, replacing ME242 |
|
128.40 € |
- |
Biomax |
1769 |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases_48 cores, replacing ME481 |
|
227.27 € |
- |
Biomax |
1773 |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases_80 cores, replacing ME803 |
|
362.09 € |
- |
Biomax |
1774 |
Malignant melanoma tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing ME804 |
|
403.18 € |
- |
Biomax |
1775 |
Malignant melanoma test tissue array with normal skin tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T382 |
|
128.40 € |
- |
Biomax |
1776 |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases_24 cores, replacing T385 |
|
128.40 € |
- |
Biomax |
1778 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases_24 cores |
|
128.40 € |
- |
Biomax |
1780 |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases_80 cores, replacing EN801 |
|
362.09 € |
- |
Biomax |
1785 |
Lymphatic tissue array with normal tissue as control, 12 cases_ 24 cores, replacing LY241 |
|
128.40 € |
- |
Biomax |
1787 |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases_48 cores, replacing MS481 |
|
362.09 € |
- |
Biomax |
1799 |
Normal small intestine tissue array, including TNM, clinical stage and pathology grade, 30 cases_ 60 cores |
|
279.91 € |
- |
Biomax |
1808 |
Retinoblastoma tissue array with adjacent normal eye tissue as control, including TNM and clinical stage, 20 cases_40 cores, replacing BC35111 |
|
279.91 € |
- |
Biomax |